Evidence map›Paper›PMID 33888982›Full record

ArticleInternational journal of nanomedicine2021

Double-Controlled Release of Poorly Water-Soluble Paliperidone Palmitate from Self-Assembled Albumin-Oleic Acid Nanoparticles in PLGA in situ Forming Implant.

Yongjun Yu, Hai V Ngo, Gang Jin, Phuong H L Tran, Thao T D Tran, Van Hong Nguyen, Chulhun Park, Beom-Jin Lee

Open access · goldAbstract read
In one paragraph

Article in International journal of nanomedicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Development of depot PLGA-basedSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 4 countries.

Yongjun YuCollege of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.
Hai V NgoCollege of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.ORCID 0000-0002-5161-7911
Gang JinCollege of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.
Phuong H L TranDeakin University, School of Medicine, Geelong, Australia.
Thao T D TranInstitute of Research and Development, Duy Tan University, Danang, 550000, Vietnam.
Van Hong NguyenPharmaceutical Engineering Laboratory, Biomedical Engineering Department, International University, Vietnam National University, Ho Chi Minh City, 70000, Vietnam.
Chulhun ParkFaculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada.ORCID 0000-0003-4951-3213
Beom-Jin LeeCollege of Pharmacy, Ajou University, Suwon, 16499, Republic of Korea.ORCID 0000-0003-0922-3289
Ajou University · KRDeakin University · AUDuy Tan University · VNUniversity of Alberta · CAVietnam National University Ho Chi Minh City · VN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate the effects of solvents on the formation of self-assembled nanonization of albumin-oleic acid conjugates (AOCs) using a solvent exchange mechanism for the construction of in situ forming implants (ISFI).

methodsA poorly water-soluble drug, paliperidone palmitate (PPP), was chosen as the model drug. AOC was synthesized with the 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) reaction. Dichloromethane, tetrahydrofuran, ethanol, N-methyl-2-pyrrolidone, dimethyl sulfoxide, and deionized water were selected to investigate the formation of self-assembled AOC nanoparticles (AONs). The volume ratios of organic solvents against water could determine the miscibility, injectability, and in situ nanonizing capability without aggregation.

resultsAs the polarity of the organic solvents increased, the AONs exhibited a spherical shape, and the larger the volume of the solvent, the smaller the size of the AONs. To use AOC in ISFI for controlled release of PPP, poly(d,l-lactide-co-glycolide) (PLGA) was combined with the AOC in 2 mL of N-methyl-2-pyrrolidone and water solution (1.8/0.2 ratio). The release rates of all formulations exhibited similar curve patterns overall but were more controlled in decreasing order as follows: AOC, PLGA, and AOC/PLGA for 14 days.

conclusionA combined formulation of AOC and PLGA was found to effectively control the initial burst release of the drug.

Indexed as

AlbuminsDelayed-Action PreparationsDimethyl SulfoxideDrug ImplantsEthanolNanoparticlesOleic AcidPaliperidone PalmitatePolylactic Acid-Polyglycolic Acid CopolymerPyrrolidinonesSolubilitySolventsSpectroscopy, Fourier Transform InfraredWaterAlbuminsDelayed-Action PreparationsDimethyl SulfoxideDrug ImplantsEthanolN-methylpyrrolidoneOleic AcidPaliperidone PalmitatePolylactic Acid-Polyglycolic Acid CopolymerPyrrolidinonesSolventsWateralbumin-oleic acid conjugatecontrolled releasein situ forming implantself-assembled nanonizationsolvent exchangesolvent type

Identifiers

PMID33888982
PMCPMC8056066
OpenAlexW3154466743

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.